Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734) in Participants With Severe Coronavirus Disease (COVID-19)

Study to Evaluate the Safety and Antiviral Activity of Remdesivir (GS-5734) in Participants With Moderate Coronavirus Disease (COVID-19) Compared to Standard of Care Treatment

A Study to Evaluate the Safety and Efficacy of Tocilizumab in Patients With Severe COVID-19 Pneumonia

CytoResc – Einsatz von CytoSorb bei COVID-19 assoziiertem Zytokinsturm

 

 

 

Stand: 08.05.2020, Quellen: www.clinicaltrials.gov, www.drks.de